Aims/hypothesis
Diabetes diagnosed <6 months is usually monogenic. However, 10-15% of cases do not have a pathogenic variant in one of the 26 known neonatal diabetes genes. We characterised infants diagnosed <6 months without a pathogenic variant to assess whether polygenic type 1 diabetes could arise at very early ages.
Methods
We ...
Aims/hypothesis
Diabetes diagnosed <6 months is usually monogenic. However, 10-15% of cases do not have a pathogenic variant in one of the 26 known neonatal diabetes genes. We characterised infants diagnosed <6 months without a pathogenic variant to assess whether polygenic type 1 diabetes could arise at very early ages.
Methods
We studied 166 individuals diagnosed <6 months in whom pathogenic variants in all 26 known genes had been excluded and compared them to individuals with monogenic neonatal diabetes (n=164) or type 1 diabetes diagnosed at 6-24 months (n=152). We assessed the type 1 diabetes genetic risk score (T1D-GRS), islet autoantibodies, C-peptide and clinical features.
Results
We found an excess of patients with high T1D-GRS; 38% (63/166) had a T1D-GRS> 95th centile of healthy controls where 5% (8/166) would be expected if all were monogenic (p<0.0001).
Individuals with a high T1D-GRS had a similar rate of autoantibody positivity to type 1 diabetes diagnosed between 6 and 24 months (41% vs. 58%, p=0.2), and had markedly reduced C-peptide (median <3pmol/L within 1 year of diagnosis), reflecting rapid loss of insulin secretion. These individuals also had reduced birthweights (median z-score -0.89) which were lowest in those diagnosed <3 months (-1.98).
Conclusions/Interpretation
We provide strong evidence that type 1 diabetes can present before age 6 months based on individuals with this extreme-early onset diabetes subtype having the classic features of childhood type 1 diabetes; high genetic risk, autoimmunity and rapid beta-cell loss. The early onset association with reduced birthweight raises the possibility that for some individuals there was reduced insulin secretion in utero. Comprehensive genetic testing for all neonatal diabetes genes remains essential for all individuals diagnosed with diabetes <6 months.